Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-20 4:14 pm Purchase | 2026-08-19 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Point72 Asset Management, L.P. | 5,687,507 5.000% | 5,214,643![]() (+1102.78%) | Filing History |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 6,723,788 6.100% | 1,090,000![]() (+19.35%) | Filing History |
| 2026-08-14 12:17 pm Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Kynam Capital Management, LP | 6,453,877 5.700% | 4,983,336![]() (+338.88%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | T. Rowe Price Associates, Inc. | 5,748,426 5.200% | 5,748,426![]() (New Position) | Filing History |
| 2026-08-14 08:32 am Sale | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital, LP | 3,592,740 3.250% | -1,824,920![]() (-33.68%) | Filing History |
| 2026-08-07 11:12 am Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | STATE STREET CORP STT | 6,124,976 5.500% | 3,745,202![]() (+157.38%) | Filing History |
| 2026-06-26 4:05 pm Purchase | 2026-06-18 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 5,633,788 5.100% | 2,124,535![]() (+60.54%) | Filing History |
| 2026-05-15 2:38 pm Purchase | 2026-03-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Bellevue Group AG | 6,726,144 6.600% | 6,726,144![]() (New Position) | Filing History |
| 2026-05-13 4:30 pm Purchase | 2026-05-11 | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 17,201,800 14.040% | 1,176,470![]() (+7.34%) | Filing History |
| 2026-05-08 4:17 pm Purchase | 2026-05-01 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital, LP | 5,417,660 5.300% | 2,892,827![]() (+114.57%) | Filing History |
| 2026-03-27 1:55 pm Sale | 2026-03-13 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | The Vanguard Group | 0 0.000% | -3,000,948![]() (Position Closed) | Filing History |
| 2026-02-17 12:52 pm Sale | 2025-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Kynam Capital Management, LP | 1,470,541 1.540% | -3,229,459![]() (-68.71%) | Filing History |
| 2026-02-13 08:53 am Sale | 2025-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Deep Track Capital, LP | 2,524,833 2.650% | -2,854,164![]() (-53.06%) | Filing History |
| 2025-11-14 5:17 pm Sale | 2025-09-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 3,200,000 3.900% | -1,100,000![]() (-25.58%) | Filing History |
| 2025-10-27 4:31 pm Purchase | 2025-10-23 | 13D | VIRIDIAN THERAPEUTICS INC VRDN | Fairmount Funds Management LLC | 16,025,330 15.140% | 468,645![]() (+3.01%) | Filing History |
| 2025-05-15 11:44 am Purchase | 2025-03-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Kynam Capital Management, LP | 4,700,000 5.760% | 4,700,000![]() (New Position) | Filing History |
| 2025-04-11 5:15 pm Purchase | 2025-04-04 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 4,300,000 5.300% | 2,375,926![]() (+123.48%) | Filing History |
| 2025-02-14 6:05 pm Unchanged | 2024-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III, L.P. | 3,575,309 4.500% | 0 (Unchanged) | Filing History |
| 2024-11-14 5:53 pm Sale | 2024-09-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Opportunities Fund L.P. | 1,882,615 2.900% | -941,306![]() (-33.33%) | Filing History |
| 2024-11-14 5:52 pm Sale | 2024-09-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Venrock Healthcare Capital Partners III, L.P. | 3,575,309 5.500% | -1,980,259![]() (-35.64%) | Filing History |

